Limagrain And Qi Biodesign Sign Worldwide Licensing Agreement For Genome Editing Technologies To Accelerate The Development Of Next-Generation Crop Varieties
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Thu, 6 August 2026
What it is about
Qi BiodesignScientific CommitteeEuropean UnionBeijing, Beijing, ChinaFranceAuvergne, Haute-Normandie, France
Who published it, and when
How it spread - 1 original report
Thu, 6 August 2026
1 report- foodonline.com12:15first to report
Limagrain and leading genome editing player Beijing Qi Biodesign Biotechnology Co., Ltd. ("Qi Biodesign") today announced a global licensing agreement granting Limagrain access to a portfolio of genome editing technologies for field and vegetable crops.